Weight-loss drugs tied to lower fracture risk in diabetes patients, study finds
A large study indicates that GLP-1 weight-loss drugs like Ozempic may reduce the risk of bone fractures in patients with type 2 diabetes. The findings challenge previous concerns that these medications could negatively impact bone health.
Weight-loss drugs tied to lower fracture risk in diabetes patients, study finds GLP-1 medicines such as Ozempic may reduce the risk of serious bone fractures in people with type 2 diabetes, according to a large study that challenges fears the blockbuster drugs could damage bone health.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in